See the DrugPatentWatch profile for advil

The new Advil formula is designed to reduce side effects by utilizing a technology called Advil Film-Coat. This technology allows the active ingredient, ibuprofen, to be released more slowly into the body, which can help minimize gastrointestinal (GI) side effects [1].

The GI tract is where many of the side effects of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen occur. These side effects can include stomach pain, ulcers, and bleeding. By releasing the drug more slowly, the new Advil formula aims to reduce the impact on the GI tract and, therefore, reduce these side effects [1].

It's important to note that, while the new formula may help reduce side effects for some people, it does not eliminate them entirely. As with any medication, it's crucial to follow the recommended dosage and consult with a healthcare provider if you have any concerns about side effects [1].

In addition, it's worth noting that the new Advil formula is covered by several patents. According to DrugPatentWatch.com, there are patents for the "pharmaceutical composition containing ibuprofen" and the "method of treating pain" using this composition [2][3]. These patents suggest that the new formula is a significant departure from previous versions of Advil.

In summary, the new Advil formula reduces side effects by using a technology called Advil Film-Coat, which releases the active ingredient, ibuprofen, more slowly into the body. This can help minimize gastrointestinal side effects. However, it's essential to follow the recommended dosage and consult with a healthcare provider if you have any concerns about side effects.

Sources:
[1] <https://www.advil.com/pain-reliever/film-coated-ibuprofen>
[2] <https://www.drugpatentwatch.com/drugs/ibuprofen>
[3] <https://patents.google.com/patent/US9265906B2/en>